Unknown

Dataset Information

0

Mechanism of Action of VP1-001 in cryAB(R120G)-Associated and Age-Related Cataracts.


ABSTRACT: Purpose:We previously identified an oxysterol, VP1-001 (also known as compound 29), that partially restores the transparency of lenses with cataracts. To understand the mechanism of VP1-001, we tested the ability of its enantiomer, ent-VP1-001, to bind and stabilize ?B-crystallin (cryAB) in vitro and to produce a similar therapeutic effect in cryAB(R120G) mutant and aged wild-type mice with cataracts. VP1-001 and ent-VP1-001 have identical physicochemical properties. These experiments are designed to critically evaluate whether stereoselective binding to cryAB is required for activity. Methods:We compared the binding of VP1-001 and ent-VP1-001 to cryAB using in silico docking, differential scanning fluorimetry (DSF), and microscale thermophoresis (MST). Compounds were delivered by six topical administrations to mouse eyes over 2 weeks, and the effects on cataracts and lens refractive measures in vivo were examined. Additionally, lens epithelial and fiber cell morphologies were assessed via transmission electron microscopy. Results:Docking studies suggested greater binding of VP1-001 into a deep groove in the cryAB dimer compared with ent-VP1-001. Consistent with this prediction, DSF and MST experiments showed that VP1-001 bound cryAB, whereas ent-VP1-001 did not. Accordingly, topical treatment of lenses with ent-VP1-001 had no effect, whereas VP1-001 produced a statistically significant improvement in lens clarity and favorable changes in lens morphology. Conclusions:The ability of VP1-001 to bind native cryAB dimers is important for its ability to reverse lens opacity in mouse models of cataracts.

SUBMITTER: Molnar KS 

PROVIDER: S-EPMC6676924 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mechanism of Action of VP1-001 in cryAB(R120G)-Associated and Age-Related Cataracts.

Molnar Kathleen S KS   Dunyak Bryan M BM   Su Bonnie B   Izrayelit Yevgeniy Y   McGlasson-Naumann Brittney B   Hamilton Paul D PD   Qian Mingxing M   Covey Douglas F DF   Gestwicki Jason E JE   Makley Leah N LN   Andley Usha P UP  

Investigative ophthalmology & visual science 20190801 10


<h4>Purpose</h4>We previously identified an oxysterol, VP1-001 (also known as compound 29), that partially restores the transparency of lenses with cataracts. To understand the mechanism of VP1-001, we tested the ability of its enantiomer, ent-VP1-001, to bind and stabilize αB-crystallin (cryAB) in vitro and to produce a similar therapeutic effect in cryAB(R120G) mutant and aged wild-type mice with cataracts. VP1-001 and ent-VP1-001 have identical physicochemical properties. These experiments ar  ...[more]

Similar Datasets

| S-EPMC4581838 | biostudies-literature
| S-EPMC5538314 | biostudies-literature
| S-EPMC5419431 | biostudies-literature
| S-EPMC3480178 | biostudies-literature
| S-EPMC8665303 | biostudies-literature
| S-EPMC8237109 | biostudies-literature
| S-EPMC7722637 | biostudies-literature
| S-EPMC3178670 | biostudies-literature
| S-EPMC4431863 | biostudies-literature
| S-EPMC3537076 | biostudies-literature